Conagra Brands is facing heightened anxiety from investors as shares dropped 4-5% following the announcement of John Brase as the new CEO, coinciding with a 44% decline in the stock over the past year. The company grapples with significant market challenges, including rising inflation costs and shifting consumer preferences, which have led to muted growth expectations. Despite potential long-term benefits from Brase's strategic initiatives aimed at recovery, analysts remain skeptical of Conagra's immediate turnaround prospects amidst ongoing pressures.

“こういうブランド力持った優良株がへなちょこの時こそ買いたいなと思いますね。”


“Realistic catalysts: - New CEO John Brase delivers sharp margin recovery via cost cuts, supply chain wins, and volume rebound (Q3 showed early organic sales lift). - Asset sales (e.g., Hebrew National) slash $7B+ net debt and fund buybacks. - Consumer staples rally on easing inflation + strong earnings beats.”

“Short-term: execution risk high. Long-term turnaround possible but $40 needs multi-year perfection + sector tailwinds.”

“The Conagra CEO transition to John Brase (ex-JM Smucker President/COO, 30+ yrs at P&G) was planned but spooked investors. CAG shares dropped 4-5% on the April 13 announcement amid ongoing pressures like soft consumer spending and a 44% 12-month decline.”

“Brase's ops/brand expertise could support revenue and margins long-term. Short-term: typical transition uncertainty. Not a slam-dunk positive yet.”

“The CAG has uncovered massive irregularities in Odisha's land transfers, revealing that SC/ST-owned land was illegally diverted to others through flawed oversight and safeguard violations.”

“Recent filings show only scattered modest buys (e.g., ~$25M total across a few firms like LW and CAG as of Apr 15).”